Back to all studies
Active Not RecruitingNCT05991167

EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")

This study is active but not recruiting. It focuses on ADHD and currently lists study information in the United States.

ADHDDevice
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT05991167. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This observational study follows people living with ADHD to understand their experience, outcomes, or changes over time.

What would participation involve?

Participants may answer questionnaires, join interviews, or provide follow-up information, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in United States.

Who is it mainly for?

This study appears to be mainly for people with ADHD.

What should you check before joining?

Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a lab, with sites including Akili Interactive Labs, Inc in Boston. Participation appears to center on questionnaires, assessments, or follow-up information rather than a study treatment. The main fit is usually being able to understand the study and consent and meeting the main study requirements. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: June 1, 2022
Recruitment status
Active Not Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Akili Interactive Labs, Inc.
Sponsor type
Other organization
Study type
Device
Intervention type
Device / app / digital / technology
Study phase
Not clearly listed
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT05991167
Official title
EndeavorRx® Prospective Product Registry ("Expedition EndeavorRx")
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT05991167. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medical device for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with adhd. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Akili Interactive Labs, Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that the study is active but not currently recruiting. This usually means participants may already be involved, but new participants may not be accepted.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me